CCL20 and metabolic dysfunction-associated steatotic liver disease: It has been reported that CCL-20 levels are significantly increased in various chronic liver diseases, such as alcoholic hepatitis and non-alcoholic fatty liver disease (NAFLD), and that CCL-20 triggers both inflammation and fibrosis in the liver [13].